Advanced 2D and 3D Imaging of Ex-Vivo Models
Utilizing cutting-edge technologies such as Operetta, confocal microscopy, Incucyte, and SPIM, we provide high-resolution imaging that captures cellular structures and dynamics in unprecedented detail. Our platform supports both 2D and 3D imaging, enabling comprehensive analysis of tissue architecture, cell interactions, and morphological changes.
AI-Driven Digital Pathology for Precision Analysis
Leveraging deep learning algorithms, we offer precise and automated analysis of tissue samples, providing rapid and accurate identification of pathological features. Our digital pathology services enhance diagnostic accuracy, enable large-scale data analysis, and support advanced research into disease mechanisms.
IMAG’IN platform (Departement de Pathology)
The Imag’IN Platform of the University Cancer Institute of Toulouse (IUC) is an IBiSA certified technological platform that provides its expertise for the design of projects involving histopathology, functional anatomy and biological imaging. We offer a complete and adaptable solution for whole-slide images acquisition and analysis either in transmitted light or fluorescence (high resolution tissue […]
Lymphoma Data Hub (LDH)
The LDH is a collaborative research platform in digital health, specialized in data management and technological support for biomedical research. Our services include secure cloud hosting for health data, end-to-end data management from raw data deposit to ready-to-use datasets, and the deployment of advanced tools to enable research projects in artificial intelligence and bioinformatics.
CeVi Collection
The CeVi collection is a unique collection of cryopreserved viable human cells from lymphomas and reactive lymphoid tissues. It is structured around a national network of Biological Resource Centres (BRCs) and is dedicated to the use of CALYM consortium members and their partners, with the aim of accelerating lymphoma research.
Multicellulare Agregates of Lymphoma Cells (MALC)
Explore complex tumor biology with our Multicellular Aggregates of Lymphoma Cells (MALC) model. It mimics the 3D structure and microenvironment of lymphoma, providing a robust system for studying cell-cell interactions, tumor progression, and therapeutic responses. The MALC model enables more physiologically relevant insights compared to traditional 2D cultures, supporting the development of targeted lymphoma therapies.
3D Co-Culture of Lymphoma Cells with Gamma Delta T Cells
Explore our 3D co-culture system combining lymphoma cell lines and gamma delta T cells from healthy donors. This advanced model recreates the tumor microenvironment, allowing detailed study of immune-tumor interactions, gamma delta T cell cytotoxicity, and potential therapeutic mechanisms.
Patient-Derived Lymphoma Spheroids (PDLS)
Explore our Patient-Derived Lymphoma Spheroids (PDLS), a cutting-edge 3D organoid model developed directly from patient samples. PDLS offer an accurate representation of tumor architecture and microenvironment, enabling the study of tumor behavior, drug response, and personalized treatment strategies.
Immunohistochemistry
We offer precise staining and analysis of tissue samples, enabling the detection and localization of specific proteins within their histological context. Our IHC platform provides critical insights into disease mechanisms, biomarker expression, and therapeutic target validation.
Multiplexed Immuno-Fluorescence
We enable simultaneous detection of multiple targets within a single tissue section, providing a detailed spatial understanding of cellular environments. Our mIF services are ideal for studying co-localization, cellular heterogeneity, and biomarker discovery.